This is consistent with the results of a meta-analysis by Lee et al. that included six studies [32], which found an increased risk of stomach cancer for BRCA1/2 GPV carriers and/or [un]tested family members in different age groups. This evidence concerns the gene BRCA1 and gastric neoplasm.